Most infants admitted to the intensive care or high acuity unit for respiratory syncytial virus (RSV) infections during fall 2022 were previously healthy and born at term, according to a new study reported in JAMA Network Open.
Purdue researcher receives $1.38 million to fight against drug-resistant malaria in developing countries
A Purdue researcher is taking a giant leap forward in the fight against drug-resistant strains of malaria in developing countries.